|
|
| Crohn's Disease | Visit Website |
1-877-240-7528 |
sales@crohns.net |
Why Shop Crohns.net? |
Quick Product Links
|
|
Crohn's Disease- Pathophysiology and Conventional and Alternative Treatment OptionsTable 1: Subcategories of Crohn's Disease Table 2: Signs and Symptoms of Crohn's Disease and Ulcerative Colitis Etiopathogenesis:
Stress in the Etiology of Crohn's Disease Other Abnormalities Contributing to the Etiopathogenesis of Crohn's Disease Conventional Treatment of Crohn's Disease Table 5: Conventional Medications and their Mechanisms in Crohn's Disease Nutrient Deficiences in Crohn's Disease Table 6: nutrient Deficiencies Associated with Crohn's Disease Dietary Interventions in Crohn's Disease Table 7: Diet Therapies Compared to Steroid Medications in Crohn's Disease Probiotics in the Treatment of Crohn's Disease Fatty Acids for the Treatment of Crohn's Disease Table 8: A Summary of Omega-3 Fatty Acid Studies in Crohn's Disease Remicade Increasing Risk of Cancer Botanicals in the Treatment of Crohn's Disease |
GlutamineThe amino acid glutamine is the preferred fuel for small intestinal enterocytes and can decrease intestinal permeability, a potential benefit for Crohns Disease patients. Duodenal biopsies from healthy volunteers were cultured in the presence of the inflammatory cytokine-enhancing IL-1beta and increasing amounts of glutamine. Glutamine inhibited IL-1beta-induced production of pro-inflammatory cytokines IL-6 (found to be high in the serum and mucosa of Crohn's Disease patients83) and IL-8, and enhanced production of the anti-inflammatory IL-10.247 Despite theoretical indications for glutamine supplementation in Crohn's Disease, several small intervention trials have not yielded benefit. In a double-blind study to determine if glutamine decreases gut permeability in Crohn’s disease, 14 Crohn's Disease patients were randomly assigned to receive 7 g glutamine or placebo (glycine) three times daily along with their conventional treatment. There were no significant changes in permeability during the four-week trial in either the glutamine or placebo groups. In addition, no significant changes were seen in CDAI, CRP, or plasma glutamine/ glutamate levels.248 Two studies investigating high-glutamine diets in children with Crohns Disease also found no significant benefit. Eighteen children received either a low-glutamine (4% of amino acid content) polymeric diet or a glutamine-enriched (42% of amino acid content) polymeric diet to determine whether glutamine enhances rate of remission. After four weeks, 5/9 in the low-glutamine group and 4/7 (two patients dropped out of this group due to diet intolerance) in the high-glutamine group achieved remission. Pediatric CDAI was significantly lower in the low-glutamine group, indicating greater response to the low- than high-glutamine diet.249 In a second arm of the study, glutamine did not affect intestinal permeability.250
Growth is often stunted by childhood Crohns Disease
and low serum levels of insulin-like growth factor-
1 (IGF-1) have been implicated. In doubleblind
fashion, 15 children with Crohn's Disease were assigned
to receive one of two diets (same amino acid content
as previous study) and the effect on IGF-1
assessed. No significant changes in IGF-1 were
noted after four weeks of supplementation.251
|
|
|
Call 1-877-240-7528 • Mon-Fri 9am-5pm PST P.O. Box 927747 ~ San Diego ~ California ~ 92192 ~ USA Home | About Us | Quick Product Links | Search | Help |
||